[Catheter ablation technologies for persistent atrial fibrillation: controversies and evaluation].

Li, S T; Li, Q F; Lai, Y W; Sang, C H; Ma, C S

Li, S T; Li, Q F; Lai, Y W; Sang, C H; Ma, C S.

Affiliation

Li ST; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing 100029, China.
Li QF; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing 100029, China.
Lai YW; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing 100029, China.
Sang CH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing 100029, China.
Ma CS; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing 100029, China.

Zhonghua Xin Xue Guan Bing Za Zhi ; 51(9): 909-914, 2023 Sep 24.

Article de Zh | MEDLINE | ID: mdl-37709706

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fibrillation auriculaire / Ablation par cathéter Limites: Humans Langue: Zh Journal: Zhonghua Xin Xue Guan Bing Za Zhi Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google